WELL Health Technologies Corp.
WELL.TOTSXHealthcare● Active
$4.84
$-0.21(-4.16%)
Market Cap$1.2B
P/E Ratio—
52W High$6.08
52W Low$3.58
WELL Health Technologies Corp. (WELL.TO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
WELL.TO · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
$0.06
Est. $0.05 · +10.2%
Revenue
$0.37B
Est. $0.37B · +0.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS✓ 3-Quarter EPS Beat Streak
WELL.TO reports quarterly as a TSX-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $7.60B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$7.60B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $0.05 | — | — | — | $0.39B | — |
| ▲ Q2 FY2026 | May 7, 2026 | $0.05 | $0.06 | +10.2% | $0.37B | $0.37B | +0.3% |
| ▲ Q1 FY2026 | Mar 19, 2026 | $0.11 | $0.20 | +88.2% | $0.38B | $0.39B | -0.1% |
| ▲ Q4 FY2025 | Nov 6, 2025 | $0.09 | $0.16 | +74.5% | $0.36B | $0.37B | -0.9% |
| ▼ Q3 FY2025 | Aug 11, 2025 | $0.09 | $0.05 | -49.2% | $0.36B | $0.35B | +0.9% |
| ▼ Q2 FY2025 | May 14, 2025 | $0.02 | -$0.19 | -1050.0% | $0.29B | $0.35B | -17.0% |
| ▼ Q1 FY2025 | Mar 28, 2025 | $0.02 | -$0.05 | -361.0% | $0.19B | $0.26B | -26.6% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -$0.01 | -$0.33 | -3399.5% | $0.25B | $0.26B | -4.2% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$0.05
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
$0.06
EPS Est.
$0.05
EPS Surpr.
+10.2%
Revenue
$0.37B
Q1 FY2026
Mar 19, 2026Beat
EPS Actual
$0.20
EPS Est.
$0.11
EPS Surpr.
+88.2%
Revenue
$0.38B
Q4 FY2025
Nov 6, 2025Beat
EPS Actual
$0.16
EPS Est.
$0.09
EPS Surpr.
+74.5%
Revenue
$0.36B
Q3 FY2025
Aug 11, 2025Miss
EPS Actual
$0.05
EPS Est.
$0.09
EPS Surpr.
-49.2%
Revenue
$0.36B
Q2 FY2025
May 14, 2025Miss
EPS Actual
-$0.19
EPS Est.
$0.02
EPS Surpr.
-1050.0%
Revenue
$0.29B
Q1 FY2025
Mar 28, 2025Miss
EPS Actual
-$0.05
EPS Est.
$0.02
EPS Surpr.
-361.0%
Revenue
$0.19B
Q4 FY2024
Nov 7, 2024Miss
EPS Actual
-$0.33
EPS Est.
-$0.01
EPS Surpr.
-3399.5%
Revenue
$0.25B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.10 | $-0.10 | $-0.09 | 2 |
| Q3 FY2027 | $-0.11 | $-0.10 | $-0.09 | 2 |
| Q2 FY2027 | $-0.12 | $-0.11 | $-0.10 | 2 |
| Q1 FY2027 | $-0.04 | $-0.04 | $-0.04 | 3 |
| Q4 FY2026 | $0.06 | $0.07 | $0.07 | 3 |
| Q3 FY2026 | $0.03 | $0.05 | $0.08 | 7 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.4B | $0.4B | $0.5B | 6 |
| Q3 FY2027 | $0.4B | $0.4B | $0.4B | 6 |
| Q2 FY2027 | $0.4B | $0.4B | $0.4B | 6 |
| Q1 FY2027 | $0.4B | $0.4B | $0.4B | 6 |
| Q4 FY2026 | $0.4B | $0.4B | $0.4B | 11 |
| Q3 FY2026 | $0.4B | $0.4B | $0.4B | 12 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +10.2% | $4.34 | $4.37 | +0.69% |
| ▲ Q1 FY2026 | Mar 19, 2026 | +88.2% | $4.21 | $4.19 | -0.48% |
| ▲ Q4 FY2025 | Nov 6, 2025 | +74.5% | $4.90 | $4.50 | -8.16% |
| ▼ Q3 FY2025 | Aug 11, 2025 | -49.2% | $4.90 | $4.81 | -1.84% |
| ▼ Q2 FY2025 | May 14, 2025 | -1050.0% | $4.19 | $4.09 | -2.39% |
| ▼ Q1 FY2025 | Mar 28, 2025 | -361.0% | $5.05 | $4.97 | -1.58% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -3399.5% | $4.52 | $4.93 | +9.07% |
| ▲ Q3 FY2024 | Aug 14, 2024 | +720.8% | $4.64 | $4.44 | -4.31% |
Q2 FY2026+0.69%
Report Date
May 7, 2026
EPS Beat/Miss
+10.2%
Price Before
$4.34
Price After
$4.37
Q1 FY2026-0.48%
Report Date
Mar 19, 2026
EPS Beat/Miss
+88.2%
Price Before
$4.21
Price After
$4.19
Q4 FY2025-8.16%
Report Date
Nov 6, 2025
EPS Beat/Miss
+74.5%
Price Before
$4.90
Price After
$4.50
Q3 FY2025-1.84%
Report Date
Aug 11, 2025
EPS Beat/Miss
-49.2%
Price Before
$4.90
Price After
$4.81
Q2 FY2025-2.39%
Report Date
May 14, 2025
EPS Beat/Miss
-1050.0%
Price Before
$4.19
Price After
$4.09
Q1 FY2025-1.58%
Report Date
Mar 28, 2025
EPS Beat/Miss
-361.0%
Price Before
$5.05
Price After
$4.97
Q4 FY2024+9.07%
Report Date
Nov 7, 2024
EPS Beat/Miss
-3399.5%
Price Before
$4.52
Price After
$4.93
Q3 FY2024-4.31%
Report Date
Aug 14, 2024
EPS Beat/Miss
+720.8%
Price Before
$4.64
Price After
$4.44
Avg Beat Reaction-3.06%
Avg Miss Reaction+0.81%
Beat Rate4 / 8 quarters
Largest Move+9.07% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: WELL.TO ends December
WELL Health Technologies Corp. (WELL.TO) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $0.06 — beating the analyst consensus of $0.05 by +10.2%. WELL.TO has beaten EPS estimates for 3 consecutive quarters. The next WELL.TO earnings date is expected around September 1, 2026.
Each quarter, investors track WELL.TO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. WELL.TO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
WELL.TO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
WELL.TO earnings · 5 questionsWELL Health Technologies Corp.'s next earnings report is expected around September 1, 2026. WELL.TO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; WELL.TO historically reports after market close (AMC).
WELL.TO earnings datewhen is WELL.TO earningsWELL.TO next earnings datewhen does WELL.TO report earningsWELL.TO earnings calendar
▸ Source: FMP · WELL Health Technologies Corp. SEC filings · US GAAP · WELL Health Technologies Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026